<unk>  is a 3rd generation cephalosporin that is FDA approved for the treatment of acute bacterial exacerbation of chronic bronchitis, community acquired pneumonia, infection of skin and/or subcutaneous tissue, and pharyngitis/tonsillitis.   Common adverse reactions include diarrhea, nausea and candida vaginitis.
Cefditoren
Meropenem
Cefepime
Aztreonam 
Ertapenem
Cefotaxime sodium
Levofloxacin 
Vancomycin 